会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Beverage
    • 饮料
    • JP2008228732A
    • 2008-10-02
    • JP2008073566
    • 2008-03-21
    • Coy Johannesヨハネス コイJohannes Coy
    • JOHANNES COY
    • A23L2/52C12G3/02C12G3/04
    • A23L2/52A23C9/1315A23C11/106A23L2/38A23L2/68A23L33/12A23L33/175A23V2002/00C12G3/04A23V2200/328A23V2200/322A23V2250/042A23V2250/186A23V2250/06
    • PROBLEM TO BE SOLVED: To provide a liquid food which is slowly drunken in a slight amount during the digestion and which does not liberate glucose. SOLUTION: This beverage has a content of fat and/or oil of at least 5% (mass/volume) and at most of 35% (mass/volume), a content of hydrocarbons of at most 1.7% (mass/volume) and a content of lactic acid, wherein a content of fat and/or oil has saturated fatty acids of at most 30% and unsaturated fatty acids of at least 20%. The unsaturated fatty acid contains ω-3 fatty acids and ω-6 fatty acids. Then, the ratio of ω-6 fatty acids to ω-3 fatty acids is 4:1 or less; the content of fat and/or oil contains vegetable oils; and the content of fat and/or oil is higher than the content of hydrocarbons. COPYRIGHT: (C)2009,JPO&INPIT
    • 要解决的问题:提供在消化期间缓慢地醉酒并且不释放葡萄糖的液体食物。 解决方案:该饮料具有至少5%(质量/体积)和至多35%(质量/体积)的脂肪和/或油的含量,烃的含量至多为1.7%(质量/ 体积)和乳酸含量,其中脂肪和/或油的含量具有至多30%的饱和脂肪酸和至少20%的不饱和脂肪酸。 不饱和脂肪酸含ω-3脂肪酸和ω-6脂肪酸。 然后,ω-6脂肪酸与ω-3脂肪酸的比例为4:1以下; 脂肪和/或油的含量含有植物油; 并且脂肪和/或油的含量高于烃的含量。 版权所有(C)2009,JPO&INPIT
    • 10. 发明公开
    • Use of inhibitors of the enzyme TKTL1.
    • Gebrauch von Inhibitoren des Enzyms TKTL1。
    • EP2256500A2
    • 2010-12-01
    • EP10009323.6
    • 2006-03-03
    • Coy, Johannes F., Dr.
    • Coy, Johannes F., Dr.
    • G01N33/68C12Q1/48G01N33/573
    • C12Q1/54C12Q1/48G01N1/30
    • The method for qualitative and quantitative detecting of the extend of use and the correct process flow of the mammalian aerobic glucose fermentation metabolic pathway (mam-aGF) in a mammalian individual is characterized in that the enzyme TKTL1 is used as indicator and target molecule and that the structural and/or functional parameter of said TKTL1 in a biological sample of said individual (patient) are taken as indication for the qualitative and quantitative run of the mam-aGF in the cells and/or tissue of said individual (patient). In combination with the use of inhibitors and activators of that mam-aGF the method is further suitable for checking and controlling the mam-aGF in an individual (patient).
    • 用于定性和定量检测哺乳动物个体中哺乳动物需氧葡萄糖发酵代谢途径(mam-aGF)的使用范围和正确工艺流程的方法的特征在于使用TKTL1酶作为指示剂和靶分子, 将所述个体(患者)的生物样品中的所述TKTL1的结构和/或功能参数作为所述个体(患者)的细胞和/或组织中mam-aGF的定性和定量运行的指示。 结合使用该mam-aGF的抑制剂和活化剂,该方法还适用于检查和控制个体(患者)中的mam-aGF。